$CATX
Perspective Therapeutics Inc

2020 Q4 Form 10-Q Financial Statement

#000143774921002347 Filed on February 09, 2021

View on sec.gov

Income Statement

Concept 2020 Q4 2019 Q4
Revenue $2.359M $2.206M
YoY Change 6.94% 15.86%
Cost Of Revenue $1.192M $1.095M
YoY Change 8.86% -3.86%
Gross Profit $1.167M $1.111M
YoY Change 5.04% 45.23%
Gross Profit Margin 49.47% 50.36%
Selling, General & Admin $1.748M $1.737M
YoY Change 0.63% -3.66%
% of Gross Profit 149.79% 156.35%
Research & Development $285.0K $277.0K
YoY Change 2.89% -33.09%
% of Gross Profit 24.42% 24.93%
Depreciation & Amortization $46.00K $48.00K
YoY Change -4.17% -4.0%
% of Gross Profit 3.94% 4.32%
Operating Expenses $2.040M $2.014M
YoY Change 1.29% -8.2%
Operating Profit -$873.0K -$903.0K
YoY Change -3.32% -36.81%
Interest Expense $5.000K $6.000K
YoY Change -16.67% -60.0%
% of Operating Profit
Other Income/Expense, Net $5.000K $6.000K
YoY Change -16.67% -60.0%
Pretax Income -$868.0K -$897.0K
YoY Change -3.23% -36.56%
Income Tax
% Of Pretax Income
Net Earnings -$868.0K -$897.0K
YoY Change -3.23% -36.56%
Net Earnings / Revenue -36.8% -40.66%
Basic Earnings Per Share -$0.01
Diluted Earnings Per Share -$10.45K -$13.31K
COMMON SHARES
Basic Shares Outstanding 83.05M 67.39M
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q4 2019 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $9.585M $3.180M
YoY Change 201.42% -59.58%
Cash & Equivalents $9.585M $3.180M
Short-Term Investments
Other Short-Term Assets $301.0K $497.0K
YoY Change -39.44% 41.6%
Inventory $665.0K $545.0K
Prepaid Expenses
Receivables $1.738M $1.409M
Other Receivables $0.00 $0.00
Total Short-Term Assets $12.29M $5.631M
YoY Change 118.24% -42.66%
LONG-TERM ASSETS
Property, Plant & Equipment $1.830M $1.736M
YoY Change 5.41% 18.01%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $119.0K $142.0K
YoY Change -16.2% -17.92%
Total Long-Term Assets $3.224M $3.302M
YoY Change -2.36% 57.91%
TOTAL ASSETS
Total Short-Term Assets $12.29M $5.631M
Total Long-Term Assets $3.224M $3.302M
Total Assets $15.51M $8.933M
YoY Change 73.66% -25.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $500.0K $632.0K
YoY Change -20.89% -47.16%
Accrued Expenses $841.0K $708.0K
YoY Change 18.79% 59.46%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.335M $1.340M
YoY Change -0.37% -18.29%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.405M $1.452M
YoY Change -3.24% 139.6%
Total Long-Term Liabilities $1.405M $1.452M
YoY Change -3.24% 139.6%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.335M $1.340M
Total Long-Term Liabilities $1.405M $1.452M
Total Liabilities $2.740M $2.792M
YoY Change -1.86% 24.31%
SHAREHOLDERS EQUITY
Retained Earnings -$89.52M -$86.21M
YoY Change 3.84% 4.78%
Common Stock $102.3M $92.35M
YoY Change 10.77% 0.45%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $12.77M $6.141M
YoY Change
Total Liabilities & Shareholders Equity $15.51M $8.933M
YoY Change 73.66% -25.0%

Cashflow Statement

Concept 2020 Q4 2019 Q4
OPERATING ACTIVITIES
Net Income -$868.0K -$897.0K
YoY Change -3.23% -36.56%
Depreciation, Depletion And Amortization $46.00K $48.00K
YoY Change -4.17% -4.0%
Cash From Operating Activities -$760.0K -$1.278M
YoY Change -40.53% 14.52%
INVESTING ACTIVITIES
Capital Expenditures -$60.00K -$106.0K
YoY Change -43.4% -7.83%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities -$60.00K -$106.0K
YoY Change -43.4% -104.72%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $9.500M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 8.465M -11.00K
YoY Change -77054.55% -90.83%
NET CHANGE
Cash From Operating Activities -760.0K -1.278M
Cash From Investing Activities -60.00K -106.0K
Cash From Financing Activities 8.465M -11.00K
Net Change In Cash 7.645M -1.395M
YoY Change -648.03% -237.98%
FREE CASH FLOW
Cash From Operating Activities -$760.0K -$1.278M
Capital Expenditures -$60.00K -$106.0K
Free Cash Flow -$700.0K -$1.172M
YoY Change -40.27% 17.08%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Trading Symbol
TradingSymbol
isr
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
dei Entity Central Index Key
EntityCentralIndexKey
0000728387
CY2020Q4 isr Accrued Payroll And Related Taxes Current
AccruedPayrollAndRelatedTaxesCurrent
211000
CY2020Q2 isr Accrued Payroll And Related Taxes Current
AccruedPayrollAndRelatedTaxesCurrent
352000
CY2020Q4 isr Accrued Payroll And Related Taxes Noncurrent
AccruedPayrollAndRelatedTaxesNoncurrent
160000
CY2020Q2 isr Accrued Payroll And Related Taxes Noncurrent
AccruedPayrollAndRelatedTaxesNoncurrent
55000
CY2019Q3 isr Aro Discount Amount Interest Rate
AroDiscountAmountInterestRate
0.051
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2573000
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Registrant Name
EntityRegistrantName
IsoRay, Inc.
dei Entity Small Business
EntitySmallBusiness
true
isr Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
8000
CY2020Q4 isr Proceeds From Issuance Of Common Stock Net Of Issuance Costs
ProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts
8500000
CY2015Q4 isr Purchase Agreement Period
PurchaseAgreementPeriod
P1Y
CY2020Q4 isr Restocking Fee Percentage
RestockingFeePercentage
0.5
CY2020Q4 isr Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodFairValue
0
CY2019Q4 isr Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodFairValue
11000
isr Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodFairValue
18000
isr Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodFairValue
14000
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
494000
CY2020Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
654000
CY2020Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
66000
CY2020Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
35000
CY2020Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
218000
CY2019Q3 isr Aro Original Obligation Amount
AroOriginalObligationAmount
704000
CY2019Q3 isr Asset Retirement Obligation After Adjustment
AssetRetirementObligationAfterAdjustment
555000
CY2019Q3 isr Gain Loss On Change In Aro Estimate
GainLossOnChangeInAROEstimate
73000
isr Gain Loss On Change In Aro Estimate
GainLossOnChangeInAROEstimate
isr Gain Loss On Change In Aro Estimate
GainLossOnChangeInAROEstimate
73000
CY2020Q4 isr Gain Loss On Change In Aro Estimate
GainLossOnChangeInAROEstimate
CY2019Q4 isr Gain Loss On Change In Aro Estimate
GainLossOnChangeInAROEstimate
isr Increase Decrease In Accrued Payroll And Related Taxes
IncreaseDecreaseInAccruedPayrollAndRelatedTaxes
-36000
isr Increase Decrease In Accrued Payroll And Related Taxes
IncreaseDecreaseInAccruedPayrollAndRelatedTaxes
114000
isr Increase Decrease In Accrued Protocol Expense
IncreaseDecreaseInAccruedProtocolExpense
31000
isr Increase Decrease In Accrued Protocol Expense
IncreaseDecreaseInAccruedProtocolExpense
-109000
isr Increase Decrease In Accrued Vacation
IncreaseDecreaseInAccruedVacation
14000
isr Increase Decrease In Accrued Vacation
IncreaseDecreaseInAccruedVacation
21000
isr Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
8000
CY2020Q2 us-gaap Accrued Vacation Current
AccruedVacationCurrent
204000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7267000
CY2020Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7517000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
102205000
CY2020Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
93592000
us-gaap Adjustment For Amortization
AdjustmentForAmortization
19000
us-gaap Adjustment For Amortization
AdjustmentForAmortization
20000
CY2019Q4 us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
11000
CY2020Q4 us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
9000
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
91000
CY2019Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
94000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
85000
CY2020Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
81000
CY2020Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
81000
CY2019Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
94000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
166000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
185000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
20497000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10790000
CY2020Q2 us-gaap Asset Retirement Obligation
AssetRetirementObligation
577000
CY2019Q2 us-gaap Asset Retirement Obligation
AssetRetirementObligation
621000
CY2020Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
593000
CY2019Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
563000
us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
16000
us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
15000
CY2020Q4 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
593000
CY2020Q2 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
577000
CY2020Q4 us-gaap Assets
Assets
15513000
CY2020Q2 us-gaap Assets
Assets
8699000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
12289000
CY2020Q2 us-gaap Assets Current
AssetsCurrent
5507000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9585000
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2392000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3180000
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5507000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
9767000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3361000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
7194000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2146000
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
87232324
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
68897779
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
87232324
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
68897779
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
87000
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
69000
CY2020Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1192000
CY2019Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1095000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2330000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2174000
us-gaap Depreciation
Depreciation
71000
us-gaap Depreciation
Depreciation
77000
CY2020Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2019Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.03
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2020Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
504000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y21D
CY2020Q4 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-7000
CY2019Q4 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
7000
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
15000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-125000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
190000
CY2020Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
7000
CY2020Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
23000
CY2020Q4 us-gaap Inventory Net
InventoryNet
665000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-7000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-7000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
CY2020Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1129000
CY2019Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1071000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2196000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2168000
CY2020Q4 us-gaap Gross Profit
GrossProfit
1167000
CY2019Q4 us-gaap Gross Profit
GrossProfit
1111000
us-gaap Gross Profit
GrossProfit
2413000
us-gaap Gross Profit
GrossProfit
2347000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-158000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-51000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-306000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
255000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
85000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-13000
CY2020Q2 us-gaap Inventory Net
InventoryNet
645000
CY2020Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
202000
CY2020Q2 us-gaap Inventory Noncurrent
InventoryNoncurrent
137000
CY2020Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
448000
CY2020Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
401000
CY2020Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
210000
CY2020Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
221000
CY2020Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
5000
CY2019Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
6000
us-gaap Investment Income Interest
InvestmentIncomeInterest
6000
us-gaap Investment Income Interest
InvestmentIncomeInterest
26000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
994000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
292000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
264000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
292000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
146000
CY2020Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
97000
CY2019Q3 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
CY2020Q4 us-gaap Liabilities
Liabilities
2740000
CY2020Q2 us-gaap Liabilities
Liabilities
2976000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1335000
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1575000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-713000
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
-868000
CY2020Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-868000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
8465000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-11000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-173000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-204000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1098000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1931000
us-gaap Net Income Loss
NetIncomeLoss
-1581000
us-gaap Net Income Loss
NetIncomeLoss
-1713000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-816000
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
-897000
CY2019Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-899000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1584000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1718000
CY2020Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5000
CY2019Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
26000
CY2020Q4 us-gaap Operating Expenses
OperatingExpenses
2040000
CY2019Q4 us-gaap Operating Expenses
OperatingExpenses
2014000
us-gaap Operating Expenses
OperatingExpenses
4000000
us-gaap Operating Expenses
OperatingExpenses
4086000
CY2020Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-873000
CY2019Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-903000
us-gaap Operating Income Loss
OperatingIncomeLoss
-1587000
us-gaap Operating Income Loss
OperatingIncomeLoss
-1739000
CY2020Q4 us-gaap Operating Lease Expense
OperatingLeaseExpense
76000
CY2019Q4 us-gaap Operating Lease Expense
OperatingLeaseExpense
73000
us-gaap Operating Lease Expense
OperatingLeaseExpense
152000
us-gaap Operating Lease Expense
OperatingLeaseExpense
147000
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
897000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
245000
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
236000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
652000
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
769000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
891000
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1001000
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.06
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y109D
CY2019Q4 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
2000
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
3000
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
5000
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
7000000
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
7000000
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
119000
CY2020Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
138000
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
101000
CY2020Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
94000
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
9000
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
11000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
173000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
204000
CY2020Q4 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
CY2020Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
301000
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
426000
CY2020Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
9500000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
8471000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
9097000
CY2020Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
9252000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1830000
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1735000
CY2020Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
1738000
CY2020Q2 us-gaap Receivables Net Current
ReceivablesNetCurrent
2044000
CY2020Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
285000
CY2019Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
277000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
597000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
510000
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
182000
CY2020Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
181000
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
181000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-89519000
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-87938000
CY2020Q4 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2359000
CY2019Q4 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2206000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
4743000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
4521000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
8000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1228000
CY2020Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
619000
CY2019Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
666000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1200000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1481000
us-gaap Share Based Compensation
ShareBasedCompensation
166000
us-gaap Share Based Compensation
ShareBasedCompensation
185000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
3777000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.65
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
2000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
8250
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
0
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
625
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
3125
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
26250
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
30000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
40000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
40000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
23000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5532000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.62
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
12000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
23000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
5532000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
0.62
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y135D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P6Y237D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P7Y135D
CY2020Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.52
CY2020Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
18269230
CY2020Q4 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
6250
CY2019Q4 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
6250
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2020Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
8471000
CY2020Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
12773000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
5723000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
7680000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
6955000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
6141000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
5095000
CY2020Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
83047000
CY2019Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
67388000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
75972000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
67388000

Files In Submission

Name View Source Status
0001437749-21-002347-index-headers.html Edgar Link pending
0001437749-21-002347-index.html Edgar Link pending
0001437749-21-002347.txt Edgar Link pending
0001437749-21-002347-xbrl.zip Edgar Link pending
ex_222836.htm Edgar Link pending
ex_222837.htm Edgar Link pending
ex_222838.htm Edgar Link pending
ex_222839.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
isr-20201231.xml Edgar Link completed
isr-20201231.xsd Edgar Link pending
isr-20201231_cal.xml Edgar Link unprocessable
isr-20201231_def.xml Edgar Link unprocessable
isr-20201231_lab.xml Edgar Link unprocessable
isr-20201231_pre.xml Edgar Link unprocessable
isr20201231_10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending